PYXS News and Press, Pyxis Oncology Inc. From 12/08/23

2023-12-08 10:00:17 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Bluebird bio, ...

2023-11-28 07:29:17 ET More on Pyxis Oncology Pyxis Oncology: Catalysts Ahead, Cash In Hand And An Acquisition Completed Seeking Alpha’s Quant Rating on Pyxis Oncology For further details see: Pyxis Oncology announces appointment of Kobayashi as CMO

BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced the appointment of Ken Kobayashi, M.D., F.A.C.P, as Chief Medical Officer (CMO), effecti...

PYX-201 (a novel first-in-concept and first-in-class tumor stroma targeting antibody-drug conjugate [ADC] product candidate) Phase 1 trial progressing with fifth dose cohort at 3.6 mg/kg ; data expected 1H 2024. PYX-106 (a fully human immunotherapy antibody candidate): Phase 1 tri...

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...

Pyxis Oncology Inc. (PYXS) is expected to report $-0.57 for Q3 2023

2023-10-13 09:00:17 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – October 13, 2023 – USA News Group –  Since September 2022, the US Food and Drug Administration (FDA) has seen new treatments for pancreatic cancer ...

BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced four abstracts for four different assets have been accepted for poster presentation at ...

2023-09-25 08:32:20 ET Courtside Group  ( PODC ) +13% . Gaucho Group Holdings ( VINO ) +8% . Pyxis Oncology ( PYXS ) +10% . Blue Hat Interactive Entertainment  ( BHAT ) +10% . ESS Tech ( GWH ) +10% to invest in ESS Tech as pa...

2023-09-19 13:37:04 ET More on Pyxis Oncology Seeking Alpha’s Quant Rating on Pyxis Oncology Historical earnings data for Pyxis Oncology Financial information for Pyxis Oncology Pyxis Oncology: Catalysts Ahead, Cash In Hand And An Acquisition Completed...